Market Overview

Benzinga's Top Upgrades

Related AGN
Glaxo Looking into Misconduct Charges - Analyst Blog
Roche Meets Sales Estimates in Q1 - Analyst Blog

Analysts at Wells Fargo upgraded Allergan (NYSE: AGN) from “market perform” to “outperform.” The target price range for Allergan has been raised from $99-$100 to $121-$122. Allergan's shares closed at $107.39 yesterday.

CRT Capital upgraded Engility Holdings (NYSE: EGL) from “fairly valued” to “buy.” The target price for Engility Holdings is set to $40. Engility Holdings' shares closed at $32.14 yesterday.

Analysts at Wells Fargo upgraded Eagle Rock Energy Partners LP (NASDAQ: EROC) from “market perform” to “outperform.” Eagle Rock Energy Partners' shares closed at $5.92 yesterday.

Posted-In: top upgradesUpgrades Analyst Ratings

 

Most Popular

Related Articles (AGN + EGL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free